Abstract 652: Exploring the therapeutic benefit of AVA-NP-695 with combination modalities in ICB refractory and rare cancers
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: University of California, San Francisco
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409690269
